(11-207) Evaluation of cefiderocol vs sulbactam/durlobactam for the treatment of carbapenem-resistant Acinetobacter baumannii infections
Wednesday, December 10, 2025
12:30 PM - 1:30 PM
Location: Bayside A, Level 1
Residency Program: Dignity Health St. Rose Dominican Hospital, Siena Campus Residency Program Type: PGY2 (Infectious Diseases Pharmacy) Residency Program Location: Nevada
